| Dr Sondema Nkipmo Tarr, DPM | |
|
4685 S Ash Ave # Siteh1, Tempe, AZ 85282-6857 | |
| (602) 638-2718 | |
| Not Available |
| Full Name | Dr Sondema Nkipmo Tarr |
|---|---|
| Gender | Female |
| Speciality | Podiatry |
| Experience | 7 Years |
| Location | 4685 S Ash Ave # Siteh1, Tempe, Arizona |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295260180 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | POD-000969 (Arizona) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Onesource Senior Healthcare Pllc | 6901026988 | 12 |
News Archive
Politico examines this critical issue and offers various scenarios of what might happen if the mandate is struck down. Meanwhile, in other health law implementation news, media outlets offer a range of stories, including reports on health exchanges and association health plans.
Quintiles' ability to provide customers with actionable early-stage data to make better development decisions faster has taken a significant step forward with the closing of the previously announced agreement to acquire Advion BioServices, a premier U.S.-based bioanalytical laboratory.
Researchers at the University of Toronto have found another clue in understanding the cause of what drives Multiple Sclerosis (MS) disease. Their findings were published today in Immunity.
AbbVie released preliminary results from an ongoing Phase I study with ABT-414, an anti-epidermal growth factor receptor (EGFR) monoclonal antibody drug conjugate, in combination with temozolomide, which showed four objective responses, including one complete response, in patients with recurrent or unresectable glioblastoma multiforme.
› Verified 3 days ago
| Provider Name | Onesource Senior Healthcare Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1508272188 PECOS PAC ID: 6901026988 Enrollment ID: O20140926000777 |
News Archive
Politico examines this critical issue and offers various scenarios of what might happen if the mandate is struck down. Meanwhile, in other health law implementation news, media outlets offer a range of stories, including reports on health exchanges and association health plans.
Quintiles' ability to provide customers with actionable early-stage data to make better development decisions faster has taken a significant step forward with the closing of the previously announced agreement to acquire Advion BioServices, a premier U.S.-based bioanalytical laboratory.
Researchers at the University of Toronto have found another clue in understanding the cause of what drives Multiple Sclerosis (MS) disease. Their findings were published today in Immunity.
AbbVie released preliminary results from an ongoing Phase I study with ABT-414, an anti-epidermal growth factor receptor (EGFR) monoclonal antibody drug conjugate, in combination with temozolomide, which showed four objective responses, including one complete response, in patients with recurrent or unresectable glioblastoma multiforme.
› Verified 3 days ago
| Provider Name | Preferred Podiatry Group Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1720037138 PECOS PAC ID: 3971412677 Enrollment ID: O20191011002269 |
News Archive
Politico examines this critical issue and offers various scenarios of what might happen if the mandate is struck down. Meanwhile, in other health law implementation news, media outlets offer a range of stories, including reports on health exchanges and association health plans.
Quintiles' ability to provide customers with actionable early-stage data to make better development decisions faster has taken a significant step forward with the closing of the previously announced agreement to acquire Advion BioServices, a premier U.S.-based bioanalytical laboratory.
Researchers at the University of Toronto have found another clue in understanding the cause of what drives Multiple Sclerosis (MS) disease. Their findings were published today in Immunity.
AbbVie released preliminary results from an ongoing Phase I study with ABT-414, an anti-epidermal growth factor receptor (EGFR) monoclonal antibody drug conjugate, in combination with temozolomide, which showed four objective responses, including one complete response, in patients with recurrent or unresectable glioblastoma multiforme.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sondema Nkipmo Tarr, DPM Po Box 772294, Detroit, MI 48277-2294 Ph: (847) 504-5000 | Dr Sondema Nkipmo Tarr, DPM 4685 S Ash Ave # Siteh1, Tempe, AZ 85282-6857 Ph: (602) 638-2718 |
News Archive
Politico examines this critical issue and offers various scenarios of what might happen if the mandate is struck down. Meanwhile, in other health law implementation news, media outlets offer a range of stories, including reports on health exchanges and association health plans.
Quintiles' ability to provide customers with actionable early-stage data to make better development decisions faster has taken a significant step forward with the closing of the previously announced agreement to acquire Advion BioServices, a premier U.S.-based bioanalytical laboratory.
Researchers at the University of Toronto have found another clue in understanding the cause of what drives Multiple Sclerosis (MS) disease. Their findings were published today in Immunity.
AbbVie released preliminary results from an ongoing Phase I study with ABT-414, an anti-epidermal growth factor receptor (EGFR) monoclonal antibody drug conjugate, in combination with temozolomide, which showed four objective responses, including one complete response, in patients with recurrent or unresectable glioblastoma multiforme.
› Verified 3 days ago
Dr. Daniel Saunders, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3231 S Country Club Way, Ste 108, Tempe, AZ 85282 Phone: 480-831-0700 Fax: 480-831-0748 | |
Dr. Patrick Gillihan, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 6301 S Mcclintock Dr Ste 115, Tempe, AZ 85283 Phone: 480-775-8460 Fax: 480-775-8464 | |
Priyanka Begur, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1920 E Baseline Rd, Tempe, AZ 85283 Phone: 800-233-3264 | |
Dr. Sina Safar, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1840 E Baseline Rd Ste A1, Tempe, AZ 85283 Phone: 480-718-5400 Fax: 877-666-4624 | |
Metro Foot & Ankle Pc Podiatrist Medicare: Medicare Enrolled Practice Location: 3231 S Country Club Way, Suite 108, Tempe, AZ 85282 Phone: 480-831-0700 Fax: 480-831-0748 | |
Direct Podiatry Arizona Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 4685 S Ash Ave # Siteh1, Tempe, AZ 85282 Phone: 602-638-2718 |